Position in APGE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,858,220
New position
Shares Held
14,000
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#159
of 285 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Carlson Capital, L.P. holds $2,624,930 across 3 Biotechnology names. APGE ranks #1 (70.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
This page
|
14,000 | $1,858,220 | |
| 2 | CYTK |
Cytokinetics Inc
|
9,000 | $766,710 | |
| 3 | 10,500 | $0 |
All Filings in APGE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,858,220 | 14,000 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||